Propanc Biopharma, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -6 | -6 | -3 |
EBITDA | -4,539 | -6,315 | -3,026 | -4,528 |
EBIT | -4,545 | -6,322 | -3,032 | -4,532 |
Net Income | -4,573 | -6,360 | -3,091 | -4,837 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,602 | -1,137 | -1,006 | -1,941 |
Cash | 832 | 443 | 561 | 602 |
Basic Shares | 1,123 | 897 | 534 | 12,331 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -22 | -21 | -17 | |
EBITDA | -18,409 | -58,339 | -1,262 | -2,255 |
EBIT | -18,432 | -58,359 | -1,283 | -2,257 |
Net Income | -18,862 | -58,923 | -1,820 | -2,660 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,682 | -405 | -935 | -1,105 |
Cash | 832 | 12 | 21 | 10 |
Basic Shares | 1,123 | 3,968 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.39 |
2025-06-30 | -$0.35 |
2025-03-31 | -$12.50 |
2024-12-31 | -$67.65 |